Structure

InChI Key RICLFGYGYQXUFH-UHFFFAOYSA-N
Smile Cl.O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1
InChI
InChI=1S/C21H31N5O2.ClH/c27-18-16-21(6-1-2-7-21)17-19(28)26(18)11-4-3-10-24-12-14-25(15-13-24)20-22-8-5-9-23-20;/h5,8-9H,1-4,6-7,10-17H2;1H

Physicochemical Descriptors

Property Name Value
Molecular Formula C21H32ClN5O2
Molecular Weight 421.97
AlogP 2.09
Hydrogen Bond Acceptor 6.0
Hydrogen Bond Donor 0.0
Number of Rotational Bond 6.0
Polar Surface Area 69.64
Molecular species NEUTRAL
Aromatic Rings 1.0
Heavy Atoms 28.0

Pharmacology

Action Mechanism of Action Reference
PARTIAL AGONIST Serotonin 1a (5-HT1a) receptor partial agonist FDA Wikipedia

Metabolites

visNetwork

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Psychotic Disorders 3 D011618 ClinicalTrials
Schizophrenia 3 D012559 ClinicalTrials
Spinal Cord Injuries 2 D013119 ClinicalTrials
Sexual Dysfunction, Physiological 2 D012735 ClinicalTrials
Postoperative Nausea and Vomiting 2 D020250 ClinicalTrials

Related Entries

Scaffolds

Parent

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
Psychiatric disorders
16.44
Nervous system disorders
15.99
General disorders and administration site conditions
15.34
Injury, poisoning and procedural complications
10.16
Musculoskeletal and connective tissue disorders
5.4
Gastrointestinal disorders
5.34
Investigations
4.36
Vascular disorders
3.98
Cardiac disorders
3.92
Respiratory, thoracic and mediastinal disorders
3.63
Skin and subcutaneous tissue disorders
3.28

Cross References

Resources Reference
ChEBI 3224
ChEMBL CHEMBL1200399
EPA CompTox DTXSID1037193
FDA SRS 207LT9J9OC
Guide to Pharmacology 36
KEGG C06861
PubChem 36431
SureChEMBL SCHEMBL41495
ZINC ZINC01530571